Nikita Shah is President & VP at Amneal Pharmaceuticals, Inc. (AMRX). They have made 10 open-market trades across 1 company since 2018, most recently 2026-08-12.
CIK 0001738061
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMRX | 253,390 | $4.9M |
Shares reported on the most recent Form 4, priced at the 2026-08-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMRX | SELL | 2026-08-12 | 2026-08-13 | $17.51 | $2.6M | +4.9% | +0.7% | — |
| AMRX | SELL | 2025-11-12 | 2025-11-14 | $11.92 | $3.1M | +7.9% | +7.4% | +26.1% |
| AMRX | SELL | 2025-08-22 | 2025-08-25 | $9.66 | $2.3M | +3.9% | +4.9% | +31.2% |
| AMRX | SELL | 2025-08-14 | 2025-08-15 | $9.29 | $1.3M | -0.7% | +3.8% | +22.2% |
| AMRX | SELL | 2025-08-12 | 2025-08-13 | $9.04 | $904K | -0.3% | +7.4% | +28.4% |
| AMRX | SELL | 2025-05-16 | 2025-05-19 | $7.58 | $745K | -2.4% | +5.9% | +23.5% |
| AMRX | SELL | 2024-08-14 | 2024-08-16 | $7.75 | $775K | +8.4% | +10.6% | +13.4% |
| AMRX | SELL | 2021-12-15 | 2021-12-17 | $3.95 | $8K | +7.8% | -0.2% | -8.0% |
| AMRX | SELL | 2021-03-15 | 2021-03-17 | $6.87 | $499K | +1.3% | -12.0% | -14.8% |
| AMRX | SELL | 2018-08-21 | 2018-08-23 | $23.46 | $1.2M | +0.0% | -1.9% | -21.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.